Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Dopamine Producing Neurons

New study supports view that Lewy bodies are not the primary cause of cell death in PD

The pathology of Parkinson’s disease is characterized by a loss of dopamine-producing neurons in the pars compacta of the substantia nigra (SN), an area of the brain associated with motor control, along with the development of α-synuclein (αS) protein in the form of Lewy bodies (LB) in the neurons that survive. The spread of… New study supports view that Lewy bodies are not the primary cause of cell death in PD   



Freezing Parkinson’s in its tracks

Parkinson’s disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It’s characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic… Freezing Parkinson’s in its tracks   



Therapeutic avenues for Parkinson’s investigated at UH

Scientists at the University of Houston (UH) have discovered what may possibly be a key ingredient in the fight against Parkinson’s disease.

Affecting more than 500,000 people in the U.S., Parkinson’s disease is a degenerative disorder of the central nervous system marked by a loss of certain nerve cells in the brain, causing a… Therapeutic avenues for Parkinson’s investigated at UH   



Drug discovery for Parkinson’s disease: LCSB researchers grow neurons in 3-D

The progressive loss of neurons in the brain of Parkinson’s patients is slow yet inexorable. So far, there are no drugs that can halt this insidious process. Researchers at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have now managed to grow the types of neurons affected starting from neuronal… Drug discovery for Parkinson’s disease: LCSB researchers grow neurons in 3-D   



I have Alzheimer Disease

irritability1 - alcohol-related brain damage1 - cognition function1 - alzheimer’s disease1 - postoperative cognitive dysfunction1 - caffeine2 - alpha-synuclein diseases1 - ireland's national dementia strategy1 - cognitive symptoms1 - cardiovascular risk factors1 - eeg1 - stress management1 - wernicke disease1 - stages of atherosclerosis1 - picks disease2 - mitochondrial function1 - angina1 - frontal-lobe degeneration1 - health and wellness1 - cognitive tests1 - amyloidosis1 - senility1 - stroke risk factors1 - degenerationist hypothesis1 - app3 - loss of memory3 - fight dementia1 - dementia risk4 - tuberculosis1 - risk of parkinson's1 -